1. Home
  2. Live Updates
  3. Matthew weston

Live Breaking News & Updates on Matthew weston

Stay informed with the latest breaking news from Matthew weston on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Matthew weston and stay connected to the pulse of your community

Anzac Day in South: Thousands gather in remembrance

Despite heavy rain and strong winds in parts of Otago and Southland, the Anzac spirit was strong and southerners turned out en masse to honour...

Southland , New-zealand , Warepa , New-zealand-general- , Dunrobin , Kaka-point , Benhar , Katea , Te-anau , Hokonui , Rongahere , Tuapeka-mouth

ASTRAZENECA : UBS keeps a Sell rating - MarketScreener

In a research note published by Matthew Weston, UBS advises its customers to Sell the stock. The target price is reviewed upwards from GBX 9900 to GBX 10500.

Matthew-weston ,

Thousands turn out for Dunedin dawn service

Throngs of people stood shoulder to shoulder and spilled into the street as the Dunedin dawn service began at 6.30am at the cenotaph in Queens...

Egypt , Matthew-weston , Stephen-jaquiery-harriet-baker , Stephen-jaquiery , Harriet-baker , William-atkinson , Teddy-baker , Cam-baker , Multinational-force , Brigadier-matthew-weston , Battalion-royal

ROCHE HOLDINGS AG : UBS remains Neutral - MarketScreener

In a research note published by Matthew Weston, UBS gives a Neutral rating to the stock. The target price is lowered from CHF 248 to CHF 238.

Matthew-weston , Markets ,

ASTRAZENECA : UBS maintains a Sell rating

The analyst from UBS, Matthew Weston, maintains his advice to sell. The target price is unchanged and still at GBX 9900.

Matthew-weston , Markets ,

Thousands gather in remembrance

Despite heavy rain and strong winds in parts of Otago and Southland, the Anzac spirit was strong and southerners turned out en masse yesterday to...

Ardmore , New-zealand-general- , New-zealand , Kaitangata , Balclutha , Tuapeka-mouth , Southland , Clutha , Mosgiel , Te-anau , Otago , Hokonui

NOVARTIS AG : UBS reaffirms its Buy rating

UBS analyst Matthew Weston maintains his Buy rating on the stock. The target price has been raised to CHF 108 from CHF 104.

Matthew-weston , Markets ,

NOVARTIS AG : UBS remains its Buy rating

In a research note published by Matthew Weston, UBS advises its customers to buy the stock. The target price continues to be set at CHF 104.

Matthew-weston , Markets ,

Novartis Ag (NVS) Q1 2024 Earnings Call Transcript

NVS earnings call for the period ending March 31, 2024.

Italy , Switzerland , Japan , China , Germany , France , United-states , Chinese , Swiss , Eric-le-berrigaud , Richard-vosser , Andrew-baum

SARTORIUS VORZUEGE : UBS sticks Neutral - MarketScreener

SARTORIUS VORZUEGE : UBS sticks Neutral - MarketScreener
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Matthew-weston ,